Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 September 2020 | Story Leonie Bolleurs | Photo Supplied
Participants in the third Amazing Race travelled through the African continent, experiencing Africa’s roots and its rich, vibrant, and diverse cultures

During the third Amazing Race presented by Organisational Development and Employee Wellness, staff had the opportunity to virtually travel through Africa. 

The aim of the race with the theme, A Journey through Africa, was to celebrate South Africa and Africa’s roots and its rich, vibrant, and diverse cultures. 

Natasha Nel, organisational development specialist and organiser of the race, says they wanted to give the 13 participating teams the opportunity to explore, learn, create, and be challenged together as they travel to some of the most interesting and exotic locations around Africa, but also in South Africa. 

Here in our own country, teams had the opportunity to experience our culture as well as the diversity of beliefs and traditions.


Here in our own country, teams had the opportunity to experience our culture as well as the diversity of beliefs and traditions.

Interactive and exciting event

Nel says staff could join the race in the convenience of their personal working space via a Zoom meeting. “They only needed to download the game that was specifically tailored for the UFS.” 

“It was a fun, interactive, and exciting event. In this unique adventure, it was interesting to see how teams worked together, made decisions, and also thought outside the box during the challenges,” she says.

Nel explains that teams were requested to take photos, answer questions, and make decisions unique to Africa and their culture. Some decisions and answers were timed. They also had to decide where they wanted to travel, but each decision and option had its costs, reward, and challenge linked to it.

We are the champions

Chanel Lewis, Aneke Kruger, Runé van der Merwe, and Lischen du Randt walked away as winners of the third Amazing Race. 

By participating in this race, the university has sponsored 13 breakfasts for the Community Chest of South Africa (this organisation’s mission is to inspire and facilitate community giving for community enhancement).


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept